Bimal R. Shah insider trades
Open-market stock purchases and sales by Bimal R. Shah, Director at Anebulo Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 6, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ANEB Anebulo Pharmaceuticals, Inc: other filings, last Apr 4, 2025